Back

Elamipretide in heart failure with reduced ejection fraction.

21 May 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Targeting mitochondria to improve outcomes in heart failure Cell Signalling HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Professor Hani Sabbah

Henry Ford Hospital, Detroit (United States of America)

3 More presentations in this session

Presentation thumbnail
Reaching the next level of drug development for heart failure: targetting mitochondria.
Professor S. Anker (Berlin, DE)
Presentation thumbnail
Elamipretide improves mitochondrial activity in the failing human heart.
Doctor B. Stauffer (Aurora, US)
Presentation thumbnail
Clinical development concepts targeting mitochondria.
Professor B. Pitt (Ann Arbor, US)

Access the full session

Session thumbnail
Targeting mitochondria to improve outcomes in heart failure

The Event

Event poster

HEART FAILURE 2016

21 May - 24 May 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources